Your browser doesn't support javascript.
loading
Nitric Oxide Synthase Inhibitors into the Clinic at Last.
Dao, Vu Thao-Vi; Elbatreek, Mahmoud H; Fuchß, Thomas; Grädler, Ulrich; Schmidt, Harald H H W; Shah, Ajay M; Wallace, Alan; Knowles, Richard.
Afiliación
  • Dao VT; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Elbatreek MH; Department of Pharmacology and Personalised Medicine, MeHNS, FHML, Maastricht, The Netherlands.
  • Fuchß T; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
  • Grädler U; Takeda GmbH (former Nycomed/Altana Pharma), Konstanz, Germany.
  • Schmidt HHHW; Takeda GmbH (former Nycomed/Altana Pharma), Konstanz, Germany.
  • Shah AM; Department of Pharmacology and Personalised Medicine, MeHNS, FHML, Maastricht, The Netherlands.
  • Wallace A; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.
  • Knowles R; Health and Life Sciences, Coventry University, Coventry, UK.
Handb Exp Pharmacol ; 264: 169-204, 2021.
Article en En | MEDLINE | ID: mdl-32797331
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Óxido Nítrico Sintasa / Óxido Nítrico Sintasa de Tipo III Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Óxido Nítrico Sintasa / Óxido Nítrico Sintasa de Tipo III Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Alemania